Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Wanting Qiang"'
Autor:
Wanting Qiang, Lina Jin, Tiancheng Luo, Yanchun Jia, Jing Lu, Jin Liu, Haiyan He, Ziliang Qian, Sridurga Mithraprabhu, Yang Liang, Robert Peter Gale, Xia Tao, Depei Wu, Juan Du
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/04201b75fff7418ba38847a749eebd3f
Autor:
Haiyan He, XI Chen, Nan Hou, Jin Liu, Wanting Qiang, Jing Lu, Lina Jin, Xiaoqiang Fan, Juan Du
Publikováno v:
HemaSphere, Vol 7, p e6511991 (2023)
Externí odkaz:
https://doaj.org/article/ead61b19a2f54e76bb33db4d87c823f1
Autor:
Juan Du, Pei Guo, Yun Wang, Haiyan He, Dongjian Chen, Jin Liu, Wanting Qiang, Jing Lu, Yang Liang
Publikováno v:
HemaSphere, Vol 7, p e1246249 (2023)
Externí odkaz:
https://doaj.org/article/0499e048ca54411b983224addbdba150
Publikováno v:
HemaSphere, Vol 7, p e44667ed (2023)
Externí odkaz:
https://doaj.org/article/f915f81f41124330b936dcc6c5f4df6f
Autor:
Wanting Qiang, Hua Jiang, Pei Guo, Jing Lu, Jin Liu, Lu Li, Haiyan He, Xiaoxia Hu, Weijun Fu, Juan Du
Publikováno v:
Blood Science, Vol 4, Iss 2, Pp 76-82 (2022)
Abstract. This study compares the efficacy, toxicity, hematopoietic recovery, and cost of stem-cell mobilization using intermediate-dose cyclophosphamide (IDCy) plus granulocyte colony-stimulating factor (G-CSF) compared with etoposide (VP-16) plus p
Externí odkaz:
https://doaj.org/article/87f67832592548d68e409b69d7fcc07b
Autor:
Xiaozhu Tang, Zhendong Deng, Pinggang Ding, Wanting Qiang, Yue Lu, Shengyao Gao, Ye Hu, Ye Yang, Juan Du, Chunyan Gu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-15 (2022)
Abstract Backgroud Multiple myeloma (MM) is an incurable plasma cell malignancy in the bone marrow (BM), while immunoglobulin D type of MM (IgD MM) is a very rare but most severe subtype in all MM cases. Therefore, systemic study on IgD MM is purpose
Externí odkaz:
https://doaj.org/article/4ec203a765474a01bb06b9776b0f9c9b
Autor:
Tiancheng Luo, Wanting Qiang, Jing Lu, Haiyan He, Jin Liu, Lu Li, Hua Jiang, Weijun Fu, Juan Du
Publikováno v:
Blood Science, Vol 3, Iss 3, Pp 78-86 (2021)
Abstract. Fluorescence in situ hybridization (FISH) evaluation is essential for initial risk stratification in multiple myeloma (MM). The presence of specific cytogenetic abnormalities (CA) confers a heterogeneity impact on prognosis. However, the cu
Externí odkaz:
https://doaj.org/article/bd711d62d58e434d86bfa7933b0cf601
Autor:
Haiyan He, Zifeng Li, Jing Lu, Wanting Qiang, Sihan Jiang, Yaochen Xu, Weijun Fu, Xiaowen Zhai, Lin Zhou, Maoxiang Qian, Juan Du
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 3, Pp n/a-n/a (2022)
Abstract Background Multiple myeloma (MM) is a clinically and biologically heterogeneous plasma‐cell malignancy. Despite extensive research, disease heterogeneity and relapse remain a big challenge in MM therapeutics. We tried to dissect this disea
Externí odkaz:
https://doaj.org/article/958432a8cd1142b3bbdd780ca4b5972d
Autor:
Jin Liu, Jing Lu, Wanting Qiang, Yanchun Jia, Haiyan He, Xiaofei Ye, Wee Joo Chng, Robert Peter Gale, Yang Liang, Jian Hou, Juan Du
Publikováno v:
Leukemia. 37:497-499
Autor:
Juan Du, Runhong Wei, Songfu Jiang, Hua Jiang, Lu Li, Wanting Qiang, Haiyan He, Lin Shi, Qiuling Ma, Kang Yu, Xiaoyuan Zhang, Hanyi Ding, Xuedong Sun, Fang Xiang, Lin Zhu, Zhi Cheng, Weijun Fu
Publikováno v:
American Journal of Hematology. 97:933-941
In this open-label, single-arm, phase I/II clinical trial, we evaluated the efficacy of anti-B cell maturation antigen (BCMA) chimeric antigen receptor (CAR)-T cell (HDS269B) therapy in 49 relapsed/refractory multiple myeloma (RRMM) patients, includi